Company news
Laboratorios Farmaceuticos Rovi, S.A. news in 2024
Laboratorios Farmaceuticos Rovi, S.A.'s news releases, calls and decks from 2024, newest first.
First nine months 2024 results press release
November 7, 2024
Laboratorios Farmaceuticos Rovi: ROVI completes the strategic review of its CDMO business
October 24, 2024
First half 2024 results press release
July 31, 2024
Laboratorios Farmaceuticos Rovi: ROVI invests 60 million euros to expand the production capacity of its San Sebastián de los Reyes plant by 31.5%
July 11, 2024
Laboratorios Farmaceuticos Rovi: ROVI forecasts potential Risperidone ISM® sales of between 200 and 300 million euros globally in upcoming years
June 24, 2024
Laboratorios Farmaceuticos Rovi: ROVI completes its new Escúzar plant by including a sodium heparin production facility
June 20, 2024
First three months 2024 results press release
May 8, 2024
Laboratorios Farmaceuticos Rovi: ROVI announces agreement to manufacture pre-filled syringes
April 25, 2024
ROVI, Insud Pharma and Innvierte (CDTI) create a company for the research and development of advanced therapies
March 12, 2024
Decks in 2024
- 9M 2024 Earnings Presentation
Earnings · 26 slides · Nov 7, 2024